IRVINE, Calif. (AP) _ Edwards Lifesciences Corp. (EW) on Wednesday reported third-quarter profit of $340.1 million.
The Irvine, California-based company said it had profit of 54 cents per share.
The results exceeded Wall Street expectations. The average estimate of 12 analysts surveyed by Zacks Investment Research was for earnings of 53 cents per share.
The medical device maker posted revenue of $1.31 billion in the period, which fell short of Street forecasts. Nine analysts surveyed by Zacks expected $1.32 billion.
For the current quarter ending in December, Edwards Lifesciences expects its per-share earnings to range from 53 cents to 59 cents.
The company said it expects revenue in the range of $1.3 billion to $1.38 billion for the fiscal fourth quarter.
Edwards Lifesciences expects full-year earnings in the range of $2.07 to $2.27 per share, with revenue ranging from $5.2 billion to $5.4 billion.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on EW at https://www.zacks.com/ap/EW
Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News